Finance News

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer

By Finance News On Mar 25, 2026

Pharma giant Merck is buying U.S. biotech firm Terns Pharmaceuticals for $6.7 billion, the company said Wednesday.

This is the third multibillion-dollar acquisition for Merck over the past year as the company looks to bulk up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.

Terns shares rose 5.3% while Merck stock was largely flat in premarket trading.

This is breaking news. Please refresh for updates.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.

Finance News 6535 posts 0 comments

A market is one of the many varieties of systems, institutions, procedures, social relations and infrastructures whereby parties engage in exchange. While parties may exchange goods and services by barter, most markets rely on sellers offering their goods or services (including labor power) in exchange for money from buyers.

Meta offers stock awards, options for executives, aggressive timing

DOD has no anti-corruption protocols for Trump children